Industry Insights on Circulating Tumor Cells (CTC) Technologies

CTC Technologies is a new market research publication announced by Reportstack. This report on Circulating Tumor Cells (CTC) Technologies gives a market insight into technologies and services used for cancer detection.The report serves as a guide to CTC industry, covering more than 190 companies that are engaged in CTC studies/screening, products and services. Major Contract Research Organizations, Research Institutes and Universities serving the CTC market are also covered in the corporate directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. 

To access full report with TOC, please visit ​CTC Technologies.

Cancer is a growing scourge as about 11 million people are being diagnosed with cancer every year and estimates say that are likely to be about 16 million new cases every year by 2020. Johnson & Johnson, through its Veridex LLC division, is the only company with FDA approval in the CTC Technologies area. The CellSearch's CTC test kit is valuable in assessing the prognosis of patients suffering from metastatic stage in breast cancer, prostate cancer and colorectal cancer. Several companies throughout the world have products in clinical trials and are expected to compete vigorously in the next few years with improvised products.

Companies Mentioned

"Abnova Corporation (Taiwan) AdnaGen AG (Germany) Advanced Cell Diagnostics, Inc. (USA) Affymetrix, Inc. (USA) ANGLE plc (UK) ApoCell, Inc. (USA) Applied Precision, Inc. (USA) Applied Spectral Imaging, Inc. (USA) Atossa Genetics, Inc. (USA) AVIVA BioSciences Corporation (USA) BioCEP Ltd. (Israel) Biocept, Inc. (USA) BioFluidica, Inc. (USA) BioView Ltd. (Israel) Cancer Research UK Manchester Institute (UK) Canopus Bioscience Ltd. (Canada) CellTraffix, Inc. (USA) Celsee Diagnostics (USA) Clearbridge BioMedics (Singapore) Creatv MicroTech, Inc. (USA) Cynvenio Biosystems, Inc. (USA) CytoTrack ApS (Denmark) DTU Fotonik (Denmark) EMD Millipore Corporation (USA) eOptra LLC (USA) Epic Sciences, Inc. (USA) F. Hoffmann-La Roche Ltd. (Switzerland) Fluidigm Corporation (USA) Fluxion Biosciences, Inc. (USA) Genoptix, Inc. (USA) GILUPI GmbH (Germany) Greiner Bio-One GmbH (Germany) iCellate® AB (Sweden) Ikonisys, Inc. (USA) IMEC (Belgium) IV Diagnostics, Inc. (USA) Janssen Diagnostics BVBA (Belgium) Janssen Diagnostics, LLC (USA) Laboratory Dr. Pachmann (Germany) Miltenyi Biotec, Inc. (USA) OncoGenex Pharmaceuticals, Inc. (USA) OncoVista Innovative Therapies, Inc. (USA) Progenics Pharmaceuticals, Inc. (USA) R.G.C.C. International GmbH (Switzerland) RareCells SAS (France) RareCyte, Inc. (USA) ScreenCell (France) Silicon Biosystems SpA (Italy) SIMFO GmbH (Germany) STEMCELL Technologies, Inc. (Canada) TeloVISION, LLC (USA) Transgenomic, Inc. (USA) Vitatex, Inc. (USA) "


Debora White

Manager - Marketing

Ph: +1-888-789-6604

Reportstack Market Research